Skip to main content
. Author manuscript; available in PMC: 2019 May 22.
Published in final edited form as: J Urol. 2017 Dec 26;199(6):1510–1517. doi: 10.1016/j.juro.2017.12.048

Table 4.

Prostate cancer specific mortality by pelvic lymph node and distant metastases vs nonmetastatic prostate cancer controlling for diagnosis year and age, race/ethnicity, tumor grade and pathology findings (all p <0.01)

  Age HR (95% CI)

All:
 None   Referent
 Pelvic lymph node  4.5 (4.2—4.9)
 Distant 21.9 (21.2—22.7)
50–74:
 None   Referent
 Pelvic lymph node  5.6 (5.2—6.1)
 Distant 35.5 (33.8—37.1)
75 or Greater:
 None   Referent
 Pelvic lymph node  2.9 (2.4—3.5)
 Distant 10.7 (10.1—11.3)